SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
View Top Employees from SynOx TherapeuticsWebsite | https://synoxtherapeutics.com/ |
Employees | 11 (10 on RocketReach) |
Founded | 2020 |
Technologies |
JavaScript,
HTML,
Polyfill
+10 more
(view full list)
|
Industry | Biotechnology Research |
Looking for a particular SynOx Therapeutics employee's phone or email?
Raymond Barlow is the CEO of SynOx Therapeutics.
10 people are employed at SynOx Therapeutics.